page 7
The Chumakov Center is developing two vaccines against the coronavirus infection based on the Delta strain, Director of the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy …
Real consumption gains slow in October amid widespread pandemic curbs
Preclinical trials of two more coronavirus vaccines are currently underway in Russia, Health Minister Mikhail Murashko said at Wednesday's meeting on the development of genetic technologies chaired by President Vladimir Putin. …
A new study of the Russian Sputnik V vaccine against the coronavirus has demonstrated its high safety and 96.3% efficacy, with over 1.2 mln people vaccinated, the Russian Direct Investment Fund (RDIF) said in a statement on …
An intranasal vaccine against coronavirus developed by the Gamaleya National Research Center for Epidemiology and Microbiology can be used for revaccination together with Sputnik Light in the future, the Center’s Director Alexander …
Israel will be ready to begin vaccinating children aged 5-11 against the coronavirus at the beginning of next week, after the special vaccine doses for that age group arrive later this week, writes …
Serbia is in the process of registering Russia’s Sputnik Light coronavirus vaccine and will soon become Europe’s first nation to use it, the press service of Nenad Popovic, Serbian minister without portfolio in charge of innovations …
The drive to achieve the necessary level of vaccination against coronavirus in Russia’s population can and should be completed within a few weeks, Russian Health Minister Mikhail Murashko said on Monday. "I think that it [the …
From November 15, Israel will open borders for foreigners inoculated with two doses of Sputnik V or a booster dose. The second dose must be received 14 or more days prior to the entry to the country but no more than six months at the …
Kyrgyzstan received today a large consignment of humanitarian aid from Russia: it consists of 200 thousand doses of the Russian vaccine against the Sputnik Light coronavirus, the Russian Embassy in Kyrgyzstan said. "The consignment …
Head of Georgia's National Centre for Disease Control (NCDC) Amiran Gamkrelidze said some people may need a fourth dose of COVID-19 vaccine. Gamkrelidze noted that people who travel often may need a fourth dose of vaccine, but …
Russian President Vladimir Putin has a high level of antibodies following his COVID-19 vaccination, so the head of state will get revaccinated according to doctors’ recommendations, Kremlin Spokesman Dmitry Peskov told reporters on …
Slightly more than half of elderly people in Russia have been vaccinated against the novel coronavirus, Health Minister Mikhail Murashko said at the Fourth Al-Russia Forum dubbed "Russia - Territory of Care" on Thursday. …
The first batch of Pfizer vaccine against coronavirus was delivered to Kazakhstan on Wednesday evening, the Kazakh Ministry of Health said. As part of the agreement, 4 million doses of Comirnaty Pfizer/BioNTech vaccines were …
Why Are The Elderly More Susceptible To COVID-19?
Russia's Gamaleya National Research Centre of Epidemiology and Microbiology is developing a medicine containing antibodies to treat coronavirus patients, the centre's director, Alexander Gintsburg, said. "We are currently …
The authorities of St. Petersburg have introduced compulsory vaccination against coronavirus infection for residents aged 60 and over. People with chronic illnesses also fall into this category. This is stated in the updated …
The United States flung its doors open to vaccinated international travelers on November 8, welcoming many visitors who've been shut out of the country for nearly 20 months. But with new requirements going into effect for U.S. air, …
So-called COVID-19 ‘green’ passports will go into force in Georgia starting December 1, Georgian PM Irakli Garibashvili announced today. People eligible for COVID-19 ‘green passports’ are fully vaccinated …
Gamaleya Center specialists have discovered that 300 antibodies are sufficient for protection against the coronavirus Delta strain, Center’s Director Alexander Gintsburg told the …
